Trexquant Investment LP Adma Biologics, Inc. Transaction History
Trexquant Investment LP
- $8.06 Billion
- Q4 2024
A detailed history of Trexquant Investment LP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 34,434 shares of ADMA stock, worth $545,434. This represents 0.01% of its overall portfolio holdings.
Number of Shares
34,434
Previous 822,621
95.81%
Holding current value
$545,434
Previous $16.4 Million
96.41%
% of portfolio
0.01%
Previous 0.22%
Shares
3 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$295 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$288 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$236 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$179 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$87.7 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.11B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...